Report of the Joint Allocation Taskforce (JAT) on the distribution of COVAX Facility secured vaccines: 8 June 2021
COVAX ALLOCATION ROUND 4 - Second Dose Needs
8 June 2021
| Meeting report

Overview
COVAX Allocation Round 4 concerns the allocation of AstraZeneca/AZD1222-Vaxzevria (“AZ”) to resolve the second dose needs of COVAX Facility participants who were previously allocated AstraZeneca/Covishield™ (“SII”) in February 2021.
WHO Team
Independent Allocation of Vaccines Group
Number of pages
18